Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The CNS disease drug developer has raised funding in a GV-backed round just four months after it emerged from UT Southwestern with $30m.

Osage University Partners backed a round for Aerovate Therapeutics that will go to testing an inhaled version of the latter’s pulmonary disease therapy.